Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Tecentriq
Pharma
Keytruda, Padcev cut risk of death by 50% in MIBC patient subset
The perioperative PD-1/ADC combo also significantly improved event-free survival by 60% versus surgery alone.
Angus Liuu
Oct 18, 2025 10:30am
Jazz, Roche's small cell lung cancer combo snags FDA approval
Oct 3, 2025 10:00am
Roche touts Tecentriq biomarker win in bladder cancer
Aug 18, 2025 4:17pm
ASCO: Roche, Jazz lung cancer win leaves room for improvement
May 22, 2025 5:00pm
Roche's Vabysmo crosses $4B mark as Polivy joins blockbuster club
Jan 30, 2025 11:06am
Merck moves a step closer with subcutaneous version of Keytruda
Nov 19, 2024 10:20am
